16.38 -0.67(-3.93%)10/04/2024
Evolus Inc (EOLS)
Evolus Inc (EOLS)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 09/27 21:00 | businesswire.com |
| Evolus, Inc. (EOLS) Q2 2024 Earnings Call Transcript | 07/31 22:22 | seekingalpha.com |
| Evolus, Inc. (EOLS) Reports Q2 Loss, Tops Revenue Estimates | 07/31 19:46 | zacks.com |
| Evolus reports first-ever adjusted profit in Q2 fueled by strong sales of Botox rival | 07/31 16:09 | reuters.com |
| Evolus, A Medical Aesthetics Player, Becomes Profitable — Two Quarters Early | 07/31 16:05 | investors.com |
| Evolus to Report Second Quarter Financial Results on July 31, 2024 | 07/17 08:00 | businesswire.com |
| Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse™ Dermal Filler Products | 06/24 08:00 | businesswire.com |
| Evolus Broadens International Presence with Launch of Nuceiva® (botulinum toxin type A) in Spain | 06/12 08:00 | businesswire.com |